Real-world data on PD-1 inhibitor therapy in metastatic melanoma.

Conclusions: The efficacy and safety of PD1 inhibitors in routine clinical practice appear comparable to that described in clinical trials.
PMID: 31151362 [PubMed - as supplied by publisher]

Source: Acta Oncologica - May 30, 2019 Category: Cancer & Oncology Authors: Arheden A, Skalenius J, Bjursten S, Stierner U, Ny L, Levin M, Jespersen H Tags: Acta Oncol Source Type: research